keyword
https://read.qxmd.com/read/38749067/allogeneic-haematopoietic-cell-transplantation-for-chronic-myeloid-leukaemia-in-switzerland-in-the-face-of-rapid-development-of-effective-drugs
#1
JOURNAL ARTICLE
Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R Passweg, Yves Chalandon
AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase inhibitors changed the treatment of CML patients dramatically. Allogeneic HCT was rapidly replaced by tyrosine kinase inhibitors as first-line treatment for CML, and the indication shifted to the treatment of non-responders, patients intolerant to tyrosine kinase inhibitors and patients whose CML is transforming to the accelerated phase and blast crisis...
May 3, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38749064/outcomes-of-conversion-surgery-for-patients-with-low-risk-papillary-thyroid-carcinoma
#2
JOURNAL ARTICLE
Helena Levyn, Daniel W Scholfield, Alana Eagan, Lillian A Boe, Ashok R Shaha, Richard J Wong, Jatin P Shah, Ian Ganly, Luc G T Morris, R Michael Tuttle
IMPORTANCE: The outcomes of patients with low-risk thyroid cancer who undergo surgery following a period of active surveillance (AS) are not well-defined. OBJECTIVE: To evaluate surgical, pathologic, and oncologic outcomes among patients undergoing conversion surgery (CS) following AS for low-risk papillary thyroid carcinoma. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, patients who underwent CS for disease progression were compared with patients who underwent CS without disease progression and with a propensity score-matched cohort of patients who underwent initial surgery (IS)...
May 15, 2024: JAMA Otolaryngology—Head & Neck Surgery
https://read.qxmd.com/read/38749033/perioperative-nivolumab-in-resectable-lung-cancer
#3
RANDOMIZED CONTROLLED TRIAL
Tina Cascone, Mark M Awad, Jonathan D Spicer, Jie He, Shun Lu, Boris Sepesi, Fumihiro Tanaka, Janis M Taube, Robin Cornelissen, Libor Havel, Nina Karaseva, Jaroslaw Kuzdzal, Lubos B Petruzelka, Lin Wu, Jean-Louis Pujol, Hiroyuki Ito, Tudor-Eliade Ciuleanu, Ludmila de Oliveira Muniz Koch, Annelies Janssens, Aurelia Alexandru, Sabine Bohnet, Fedor V Moiseyenko, Yang Gao, Yasutaka Watanabe, Cinthya Coronado Erdmann, Padma Sathyanarayana, Stephanie Meadows-Shropshire, Steven I Blum, Mariano Provencio Pulla
BACKGROUND: Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy) with nivolumab may further improve clinical outcomes. METHODS: In this phase 3, randomized, double-blind trial, we assigned adults with resectable stage IIA to IIIB NSCLC to receive neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo every 3 weeks for 4 cycles, followed by surgery and adjuvant nivolumab or placebo every 4 weeks for 1 year...
May 16, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38749030/carbon-footprint-analyses-in-rcts-toward-sustainable-clinical-practice
#4
JOURNAL ARTICLE
Lena B Nordberg, Heiko Pohl, Espen A Haavardsholm, Siri Lillegraven, Michael Bretthauer
No abstract text is available yet for this article.
May 15, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38749028/long-term-levels-of-protection-of-different-types-of-immunity-against-the-omicron-variant-a-rapid-literature-review
#5
REVIEW
Sabina Rodriguez Velásquez, Loza Estifanos Biru, Sandrine Marie Hakiza, Muaamar Al-Gobari, Isotta Triulzi, Jyoti Dalal, Camille Beatrice Gaza Varela, Sara Botero Mesa, Olivia Keiser
INTRODUCTION: With the emergence of newer SARS-CoV-2 variants and their substantial effects on the levels and duration of protection against infection, an understanding of these characteristics of the protection conferred by humoral and cellular immunity can aid in the proper development and implementation of vaccine and safety guidelines. METHODS: We conducted a rapid literature review and searched five electronic databases weekly from 1 November 2021 to 30 September 2022...
May 6, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38749027/mitigating-time-toxicity-in-lymphoma-and-multiple-myeloma
#6
REVIEW
Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee
The concept of time toxicity in oncology refers to the presence of frequent healthcare-related interactions that can interfere with patient well-being. In this review, we examine several manifestations of time toxicity in non-Hodgkin lymphoma and multiple myeloma and discuss their impact on decision-making with patients. For example, time toxicity may influence the choice of chemoimmunotherapy versus lenalidomide-rituximab in follicular lymphoma. In myeloma, it may inform the optimal dosing schedule for proteasome inhibitors and bisphosphonates...
May 15, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38749026/natural-language-processing-for-work-related-stress-detection-among-health-professionals-protocol-for-a-scoping-review
#7
REVIEW
Jannic Stefan Bieri, Catherine Ikae, Souhir Ben Souissi, Thomas Jörg Müller, Margarithe Charlotte Schlunegger, Christoph Golz
BACKGROUND: There is an urgent need worldwide for qualified health professionals. High attrition rates among health professionals, combined with a predicted rise in life expectancy, further emphasize the need for additional health professionals. Work-related stress is a major concern among health professionals, affecting both the well-being of health professionals and the quality of patient care. OBJECTIVE: This scoping review aims to identify processes and methods for the automatic detection of work-related stress among health professionals using natural language processing (NLP) and text mining techniques...
May 15, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38749024/an-internet-based-intervention-to-increase-the-ability-of-lesbian-gay-and-bisexual-people-to-cope-with-adverse-events-single-group-feasibility-study
#8
JOURNAL ARTICLE
Andreea Bogdana Isbășoiu, Florin Alin Sava, Torill M B Larsen, Norman Anderssen, Tudor-Stefan Rotaru, Andrei Rusu, Nastasia Sălăgean, Bogdan Tudor Tulbure
BACKGROUND: Lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people are at higher risk of mental health problems due to widespread hetero- and cisnormativity, including negative public attitudes toward the LGBTQ+ community. In addition to combating social exclusion at the societal level, strengthening the coping abilities of young LGBTQ+ people is an important goal. OBJECTIVE: In this transdiagnostic feasibility study, we tested a 6-week internet intervention program designed to increase the ability of nonclinical LGBTQ+ participants to cope with adverse events in their daily lives...
May 15, 2024: JMIR Formative Research
https://read.qxmd.com/read/38749022/long-term-results-of-the-sequential-combination-of-cladribine-and-rituximab-in-hairy-cell-leukemia
#9
JOURNAL ARTICLE
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, David McCue, Fadi G Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey Jorgensen, Sa A Wang, Keyur Patel, Sanam Loghavi, Susan O'Brien, Farhad Ravandi
We report on the long-term efficacy and safety of a phase 2 trial of sequential cladribine and rituximab in hairy cell leukemia (HCL). One-hundred and thirty-nine patients were enrolled: 111 in the frontline setting, 18 in first relapse, and 10 with variant HCL (HCLv). A complete response (CR) was achieved in 133 of 137 evaluable participants (97%) with measurable residual disease (MRD) negativity in 102 (77%). MRD status was not associated with significant differences in event-free survival (EFS) or overall survival (OS)...
May 15, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38749020/self-efficacy-and-consistent-condom-use-by-people-living-with-hiv-and-seroconcordant-and-serodiscordant-sexual-partners-in-the-cear%C3%A3-brazil
#10
JOURNAL ARTICLE
Larissa Rodrigues Siqueira, Gilmara Holanda da Cunha, Marcos Venícios de Oliveira Lopes, Maiara Bezerra Dantas, Maria Elisa Curado Gomes, Wilson Correia de Abreu, Simone de Sousa Paiva
The objectives were to assess the self-efficacy and consistent condom use by people living with HIV (PLHIV). A cross-sectional, comparative study was carried out in outpatient clinics in Ceará State, Brazil, with a sample of 190 PLHIV, 95 serodiscordant and 95 seroconcordant. Interviews were conducted using the Socio-Demographic, Clinical, Epidemiological and Vulnerability Form and the Condom Use Self-Efficacy Scale. Descriptive analysis, associations between variables, odds ratio and 95% confidence interval were determined...
May 15, 2024: AIDS Care
https://read.qxmd.com/read/38749018/an-examination-of-executive-functioning-in-adolescents-with-fasd-in-a-self-regulation-intervention
#11
JOURNAL ARTICLE
Aamena Kapasi, Jacqueline Pei, Katherine Flannigan, Kaitlyn McLachlan, Tim Oberlander, Carmen Rasmussen
Adolescents with Fetal Alcohol Spectrum Disorder (FASD) often have challenges with executive functioning (EF), which impacts their ability to self-regulate. In this study, 23 adolescents with FASD completed a self-regulation intervention. The intervention was a manualized Teen Adaptation of the Alert Program®. A nonrandomized waitlist control design was used, and participants completed pre- and post-testing using performance-based measures of EF, and rating scales of EF were completed by caregivers. Results were analyzed three ways; 1) intervention and waitlist control group comparison, 2) whole sample pre-and post- test comparison, and 3) using Reliable Change Indexes to examine individual-level clinically relevant changes...
May 15, 2024: Applied Neuropsychology. Child
https://read.qxmd.com/read/38749017/comparison-of-the-pregnancy-outcomes-of-progestin-primed-vs-antagonist-ovarian-stimulation-in-patients-with-poor-ovarian-response-a-retrospective-study
#12
COMPARATIVE STUDY
Zuoping Shi, Wenhui Zhao, Xueqing Wu, Xingyu Bi
OBJECTIVES: Progestin-primed ovarian stimulation (PPOS) is an efficient controlled ovarian stimulation (COS) method. The study explored the pregnancy outcomes between PPOS and antagonist ovarian stimulation protocol (GnRH-ant) in infertile patients with poor ovarian response (POR). METHODS: This retrospective study included patients with POR who underwent COS at the Reproductive Medical Center of Shanxi Maternal and Child Health Hospital from January 2021 to April 2022...
May 6, 2024: Gynecological Endocrinology
https://read.qxmd.com/read/38749007/validity-of-acoustic-measures-obtained-using-various-recording-methods-including-smartphones-with-and-without-headset-microphones
#13
JOURNAL ARTICLE
Shaheen N Awan, Ruth Bahr, Stephanie Watts, Micah Boyer, Robert Budinsky, Yael Bensoussan
PURPOSE: The goal of this study was to assess various recording methods, including combinations of high- versus low-cost microphones, recording interfaces, and smartphones in terms of their ability to produce commonly used time- and spectral-based voice measurements. METHOD: Twenty-four vowel samples representing a diversity of voice quality deviations and severities from a wide age range of male and female speakers were played via a head-and-thorax model and recorded using a high-cost, research standard GRAS 40AF (GRAS Sound & Vibration) microphone and amplification system...
May 15, 2024: Journal of Speech, Language, and Hearing Research: JSLHR
https://read.qxmd.com/read/38749005/quercetin-loaded-bioglass-injectable-hydrogel-promotes-m6a-alteration-of-per1-to-alleviate-oxidative-stress-for-periodontal-bone-defects
#14
JOURNAL ARTICLE
Huimin Zhu, Chao Cai, Yeke Yu, Yuning Zhou, Shiyuan Yang, Yue Hu, Yan Zhu, Jia Zhou, Jieyun Zhao, Hailong Ma, Yujie Chen, Yuanjin Xu
Periodontal disease ranks third among noncommunicable illnesses, behind cancer and cardiovascular disease, and is closely related to the occurrence and progression of various systemic diseases. However, elucidating the processes of periodontal disease and promoting periodontal bone regeneration remains a challenge. Here, quercetin is demonstrated to reduce the oxidative stress state of orofacial mesenchymal stem cells (OMSCs) in vitro and to affect the osteogenic growth of OMSCs through molecular mechanisms that mediate the m6A change in Per1...
May 15, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38749000/psychological-distress-over-12-months-post-diagnosis-in-an-early-inflammatory-arthritis-cohort
#15
JOURNAL ARTICLE
Lucy Zhao, James Galloway, Jo Ledingham, Sarah Gallagher, Gerasimina Garnavos, Paul Amlani-Hatcher, Nicky Wilson, Lewis Carpenter, Kirsty Bannister, Sam Norton
OBJECTIVES: People with inflammatory arthritis (IA) experience worsened mental wellbeing alongside disease progression. Using the National Early Inflammatory Arthritis Audit (NEIAA), we assessed trends in psychological distress during 12-months following IA diagnosis, mapping these against clinical outcomes to identify associations. METHODS: This is a prospective study of people recruited to NEIAA receiving an IA diagnosis and completing the baseline patient survey...
May 15, 2024: Rheumatology
https://read.qxmd.com/read/38748997/group-size-an-active-ingredient-of-school-based-language-therapy
#16
JOURNAL ARTICLE
Carrie Hutchins, Mary Beth Schmitt
PURPOSE: This study explored the relation between therapy group size and language outcomes for children receiving school-based language therapy through an implementation science lens. METHOD: Data for the current study were gathered as part of the Speech-Language Therapy Experiences in Public Schools study. Participants included 273 English-speaking kindergarten through second-grade children with language impairment receiving business-as-usual therapy on the caseloads of 75 speech-language pathologists...
May 15, 2024: Language, Speech, and Hearing Services in Schools
https://read.qxmd.com/read/38748992/the-effect-of-budesonide-formoterol-powder-inhalation-on-cough-and-lung-function-following-thoracoscopic-pulmonary-surgery-a-retrospective-cohort-study
#17
JOURNAL ARTICLE
Jingyao Sun, Zhaoyao Hou, Tian Xia, Chang Liu, Qiangwen Huang, Li Wei
OBJECTIVES: To explore whether portable budesonide-formoterol powder inhalation can ameliorate cough symptoms and improve pulmonary function recovery in patients who underwent thoracoscopic lung surgery. METHODS: Clinical data of patients who underwent thoracoscopic pulmonary resection at Henan Provincial People's Hospital between December 2022 and May 2023 were extracted. To evaluate the impact of continuous post-operative use of portable budesonide-formoterol powder inhalation, patients were divided into two groups: the control group and the case group...
May 15, 2024: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/38748991/a-general-framework-for-developing-computable-clinical-phenotype-algorithms
#18
JOURNAL ARTICLE
David S Carrell, James S Floyd, Susan Gruber, Brian L Hazlehurst, Patrick J Heagerty, Jennifer L Nelson, Brian D Williamson, Robert Ball
OBJECTIVE: Present a general framework providing high-level guidance to developers of computable algorithms for identifying patients with specific clinical conditions (phenotypes) through a variety of approaches, including but not limited to machine learning and natural language processing methods to incorporate rich electronic health record data. MATERIALS/METHODS: Drawing on extensive prior phenotyping experiences and insights derived from three algorithm development projects conducted specifically for this purpose, our team with expertise in clinical medicine, statistics, informatics, pharmacoepidemiology, and healthcare data science methods conceptualized stages of development and corresponding sets of principles, strategies, and practical guidelines for improving the algorithm development process...
May 15, 2024: Journal of the American Medical Informatics Association: JAMIA
https://read.qxmd.com/read/38748986/population-effectiveness-of-dolutegravir-implementation-in-uganda-a-prospective-observational-cohort-study-disco-48-week-results
#19
JOURNAL ARTICLE
Suzanne M McCluskey, Winnie R Muyindike, Victoria Nanfuka, Daniel Omoding, Nimusiima Komukama, Ian T Barigye, Lydia Kansiime, Justus Tumusiime, Taing N Aung, Ashley Stuckwisch, Bethany Hedt-Gauthier, Vincent C Marconi, Mahomed-Yunus S Moosa, Deenan Pillay, Jennifer Giandhari, Richard Lessells, Ravindra K Gupta, Mark J Siedner
BACKGROUND: Tenofovir/lamivudine/dolutegravir (TLD) is the preferred first-line antiretroviral therapy (ART) regimen for people with HIV (PWH), including those who were previously virologically suppressed on non-nucleoside reverse transcriptase inhibitors (NNRTIs). We sought to estimate the real-world effectiveness of the TLD transition in Ugandan public-sector clinics. METHODS: We conducted a prospective cohort study of PWH ≥18 years who were transitioned from NNRTI-based ART to TLD...
May 16, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38748981/impact-of-genomic-alterations-on-efficacy-of-trastuzumab-deruxtecan-against-human-epidermal-growth-factor-receptor-2-positive-advanced-gastric-cancer
#20
JOURNAL ARTICLE
Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, Hirofumi Ohmura, Tomoyasu Yoshihiro, Kenro Tanoue, Satoshi Nishiyori, Eiji Iwama, Takahiro Maeda, Koichi Akashi, Eishi Baba
PURPOSE: The impact of genomic alterations on response and resistance to trastuzumab deruxtecan (T-DXd) has not been elucidated. Thus, we sought to identify factors predicting sensitivity to T-DXd in gastric or gastroesophageal junction (G/GEJ) cancer. METHODS: We conducted a retrospective study using real-world clinical data and next-generation sequencing-based comprehensive genomic profiling (CGP) data from patients with advanced G/GEJ cancers, collected by the nationwide database in Japan...
May 2024: JCO Precision Oncology
keyword
keyword
45205
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.